Abstract
Rapid reverse phase TLC-densitometry and HPLC-UV detection methods were developed and validated for simultaneous determination of fenofibrate (FBT), its metabolite fenofibric acid (FFA) and co-formulated/ co-administered statins; rosuvastatin (RST) or atorvastatin (AST). The first method was based on reversed phase (C18) thin layer chromatographic separation of the studied drugs followed by densitometric measurements. The second method was based on isocratic reverse-phase liquid chromatographic separation of the selected compounds on C18 column (250 x 4.6 mm, 10 µ) maintained at controlled temperature (25°C). The mobile phase consisted of acetonitrile-water (82:18, v/v) and quantification was made at 254 nm for both methods. The flow rate was maintained at 1.5 mL/ min. The calibration graphs were linear in the concentration ranges of 0.25 - 4 µg/ spot and 5.0 - 50 µg mL-1 for C18 TLC-densitometry and HPLC-UV methods respectively. The developed methods were validated for specificity, linearity, precision, accuracy, and robustness. All criterions were within the acceptable range for the studied compounds. Statistical analyses proved that the investigated assays were incomparable. Moreover HPLC method was applied for determination of FBT and its metabolite and co-administered statins in human plasma. The assay procedure involved a simple one-step extraction of FBT, FFA, RST and AST from human plasma by salting out with sodium chloride and 0.1% orthophosphoric acid. The chromatographic separation was obtained within 5.4 min.
Keywords: C18 TLC-densitometry, fenofibrate, HPLC-UV, human plasma, metabolite, statins, validation.
Current Chromatography
Title:Simultaneous Determination of Fenofibrate, its Metabolite and Co- Formulated/Administered Statins Using Reverse Phase TLC-Densitometry and HPLC-UV Methods: Application in Human Plasma
Volume: 2
Author(s): Nahla Nour El-Din Ahmad Salama
Affiliation:
Keywords: C18 TLC-densitometry, fenofibrate, HPLC-UV, human plasma, metabolite, statins, validation.
Abstract: Rapid reverse phase TLC-densitometry and HPLC-UV detection methods were developed and validated for simultaneous determination of fenofibrate (FBT), its metabolite fenofibric acid (FFA) and co-formulated/ co-administered statins; rosuvastatin (RST) or atorvastatin (AST). The first method was based on reversed phase (C18) thin layer chromatographic separation of the studied drugs followed by densitometric measurements. The second method was based on isocratic reverse-phase liquid chromatographic separation of the selected compounds on C18 column (250 x 4.6 mm, 10 µ) maintained at controlled temperature (25°C). The mobile phase consisted of acetonitrile-water (82:18, v/v) and quantification was made at 254 nm for both methods. The flow rate was maintained at 1.5 mL/ min. The calibration graphs were linear in the concentration ranges of 0.25 - 4 µg/ spot and 5.0 - 50 µg mL-1 for C18 TLC-densitometry and HPLC-UV methods respectively. The developed methods were validated for specificity, linearity, precision, accuracy, and robustness. All criterions were within the acceptable range for the studied compounds. Statistical analyses proved that the investigated assays were incomparable. Moreover HPLC method was applied for determination of FBT and its metabolite and co-administered statins in human plasma. The assay procedure involved a simple one-step extraction of FBT, FFA, RST and AST from human plasma by salting out with sodium chloride and 0.1% orthophosphoric acid. The chromatographic separation was obtained within 5.4 min.
Export Options
About this article
Cite this article as:
El-Din Ahmad Salama Nahla Nour, Simultaneous Determination of Fenofibrate, its Metabolite and Co- Formulated/Administered Statins Using Reverse Phase TLC-Densitometry and HPLC-UV Methods: Application in Human Plasma, Current Chromatography 2015; 2 (1) . https://dx.doi.org/10.2174/2213240601666140917005519
DOI https://dx.doi.org/10.2174/2213240601666140917005519 |
Print ISSN 2213-2406 |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2414 |
Related Articles
-
Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches
Current Pharmaceutical Design Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease
Current Vascular Pharmacology Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions
Current Alzheimer Research Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Brain local and regional neuroglial alterations in Alzheimer´s Disease: cell types, responses and implications.
Current Alzheimer Research Yielding Criterion of Porcine Thoracic Aorta
Recent Patents on Cardiovascular Drug Discovery Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Current Molecular Medicine EDITORIAL [Pharmacological Treatments for Obesity and Obesity-Hypertension (Guest Editor: Kazuko Masuo)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design Role of Natriuretic Peptide Family in Cardiovascular Medicine
Cardiovascular & Hematological Agents in Medicinal Chemistry Epidemiology, Prognosis and Prevention of Non-Traumatic Intracerebral Hemorrhage
Current Pharmaceutical Design CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Diabetes in Racial and Ethnic Minorities in the United States: Individualizing Approaches to Diagnosis and Management
Current Diabetes Reviews The Predictive Value of Vessel-Based Calcium Score in the Detection of Coronary Stenosis
Current Medical Imaging Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology Evaluation of the Antipsychotic Effects of 2-(dimethylamino)- and 2-(methylamino)-7H-naphtho[1,2,3-de]quinolin-7-one Derivatives in Experimental Model of Psychosis in Mice
Current Topics in Medicinal Chemistry Editorial [Hot topic: Melatonin and Brain (Guest Editor: Dun-Xian Tan)]
Current Neuropharmacology Nitroimidazole Radiopharmaceuticals in Hypoxia: Part II Cytotoxicity and Radiosensitization Applications
Current Radiopharmaceuticals Acknowledgements to Reviewers
Current Vascular Pharmacology